Form D · Biotechnology
Gameto, Inc.
Bee Cave, TX · CIK 0001901628
Offering snapshot reported Aug 26, 2025 · SEC filing
- Reported sold
- $44M Offering amount: $44M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2025 | Initial | $43,999,930 | No comparison | 22 | SEC filing |
| May 29, 2024 | Initial | $42,999,962 | No comparison | 26 | SEC filing |
| Sep 7, 2022 | Initial | $9,561,635 | No comparison | 10 | SEC filing |
| Sep 7, 2022 | Amendment | $26,999,944 | $6,999,997vs Jan 11, 2022 | 20 | SEC filing |
| Jan 11, 2022 | Initial | $19,999,947 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555825
Source: Form D, filed Aug 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Hostens | Director |
| Dylan Morris | Director |
| Dusan Perovic | Director |
| Dina Radenkovic | Director, Executive |
| Maryanna Saenko | Director |
| Kristina Simmons | Director |
| Martin Varsavsky | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12117 Bee Caves Road Suite 160
Bee Cave, TX, 78738
Bee Cave, TX, 78738